RxDoctor Payments Data

Allison Wyll, MD

Otolaryngology · Dallas, TXNPI 1063408268

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,738 of the $5,972 with a category attached, or 79.3%. 18 manufacturers reported payments, led by Aerin Medical Inc. at 48.6% of the total. Reporting peaked in 2020 at $2,388 and has fallen 76.9% since, to $550 in 2025.

$5,972in general payments, 2019–2025

Across 111 payments — averaging $53.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aerin Medical Inc.$3K
  • Acclarent, Inc$976
  • Integra Lifesciences Corporation$553
  • Optinose US, Inc.$312
  • Stryker$251
  • Medtronic$188
  • plus $788 from 12 others
$1,500in research payments, 2019–2025

Across 1 payment — averaging $1500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • E.r. Squibb & Sons, L.L.C.$2K

What the payments were for

  • Travel & lodging$1,23521%
  • Food & beverage$4,73879%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,972 in reported general payments places this provider in the 80th percentile of 729 otolaryngology providers in Texas.

See all otolaryngology providers in Texas →

Medicare billing

Part B allowed, 2024
$263,085
Medicare patients
235
Services billed
757

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide99$2,686
Doxycycline Hyclate32$315
Methylprednisolone54$288
Fluticasone Propionate12$180
CefuroximeCefuroxime Axetil12$176
Ciprofloxacin Hcl21$173
Prednisone49$127
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen12$111
Mupirocin15$102

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Dallas

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →